Is There A Cure For Hearing Loss? | 2022 Hearing Loss Cure Update

Woman seeks cure for hearing loss

After realising they suffer from hearing loss or deafness, some patients seek medical help in hopes of fully recovering from hearing impairment. However, hearing loss is complex because numerous potential causes require different treatment methods. Unfortunately, there is often no known surgery or drug that could cure hearing loss.

Treatment for Different Hearing Loss Types

There are three main types of hearing loss, which require different treatment methods.

1. Conductive Hearing Loss

If you are diagnosed with conductive hearing loss, it means that sound cannot effectively pass through the external auditory canal to the eardrum and the small bones within your ears. It is related to various causes, including ear infections, congenital malformations of the outer or middle ear etc. Surgery (especially for congenital causes) or medication (such as antibiotics for ear infections) are usually used as treatment.

2. Sensorineural Hearing Loss

Also known as nerve-related hearing loss, sensorineural hearing loss is caused by damage in the inner ear or the nerve that connects the inner ear to the brain. The main causes of this type of hearing loss include head trauma, prolonged exposure to noise, disease, ototoxic drugs (drugs that damage hearing), and ageing. We do not know how to repair or replace inner ear cells once they are damaged. However, immediate medical help can slow down hearing health deterioration.

3. Mixed Hearing Loss

Mixed hearing loss is primarily caused by chronic suppurative otitis media or advanced otosclerosis. This could be treatable, especially with early medical attention. In the later stage, people usually wear hearing aids.

The Ongoing Search for a Hearing Loss Cure

For decades, researchers in labs worldwide have been working to find a cure for hearing loss. In particular, they have been working on a cure for sensorineural hearing loss.

So far, no cure is available, but will there ever be a cure for sensorineural hearing loss?


There are several ongoing projects which seem promising, and a hearing loss cure could be on the horizon:

Stem Cell Research

Researchers are investigating the potential of having stem cells develop to - and function as - hair cells. Scientists have discovered the presence of stem cells in the inner ears of mice, chicks, and zebrafish. Stem cells can under the right conditions develop into cells that are remarkably similar to hair cells. Although a cure does not yet exist, the results obtained thus far are promising. Researchers at Stanford Medicine, Rutgers University, MIT, Brigham and Women’s Hospital, and Massachusetts Eye and Ear have all been making progress with research involving stem cells and hearing loss. Besides, scientists at Kyoto University in Japan have conducted research that may help with hearing loss and tinnitus.

Progenitor Cell Activation Research

A biotech company called Frequency Therapeutics is developing an injectable drug called FX-322 to treat sensorineural hearing loss by regenerating hair cells through the activation of cells already present in the cochlea. The working principle is called progenitor cell activation, which is similar to - but not the same as - stem cell research. FX-322 uses progenitor cells to generate inner hair cells and restore hearing ability.

What Is the Progress of FX-322 So Far?

FX-322 has to pass a series of clinical trials to convince the United States Food and Drug Administration (FDA) that it is safe, reliable and effective. 

Already, FX-322 has undergone five studies with 193 subjects treated without any severe adverse events. Data from three of the studies showed statistically significant improvements in speech recognition scores:

In March 2021, Frequency Therapeutics released some promising study data. Subjects were injected with a single dose of FX-322 in one ear and a placebo in the other ear. 34% of participants saw statistically significant improvements in word recognition scores in the treated ear after 90 days.  

In another study, which enrolled 23 participants, 33% of the treated subjects demonstrated an improvement of 10% or more in word recognition scores in the treated ear. Three out of five continued to have a meaningful improvement when measured again 13-21 months later.

FX-322 was also trialled among people with severe sensorineural hearing loss. While the results did not show any improvement in the regular word recognition scores, some subjects performed better in the Bamford-Kowla-Bench Sentence-in-Noise exam (BKB-SIN).

What’s Next for FX-322 and Frequency Therapeutics in 2022 and Beyond?

Frequency Therapeutics has started a Phase 2b clinical study based on what they learned from the previous studies. 

Around 124 participants will enrol in this new study, which should finish around November 2022.

The first patient received their dose of FX-322 in October 2021, and they had to first pass through a month-long screening period to confirm their eligibility. This time, candidate subjects have to produce consistent test results across three clinic visits before participating. 

The study is designed in this way because the researchers speculate that some participants eager to receive the experimental drug might have exaggerated their hearing difficulties. 

Data published in March 2021 supported this speculation: Both the treated and placebo groups saw improved word recognition scores. Participants in the placebo group did not actually receive FX-322, so one would not expect to see any improvement in word recognition scores.

In the current FX-322 study, participants receive one injection of either the drug or a placebo. The investigators will see whether speech perception, measured by word recognition scores, have improved after 90 days. 

Subjects need to have been diagnosed with noise-induced sensorineural hearing loss or idiopathic sudden sensorineural hearing loss with hearing thresholds 35-85 dBHL. Addressing age-related hearing loss is currently not the focus of FX-322.   

Those looking for a cure for age-related hearing loss might be pleased to learn that Frequency Therapeutics is working on a new drug candidate called FX-345. The main difference between FX-322 and FX-345 is that FX-345 targets areas deeper into the cochlea, which the researchers hope will enable them to address additional sensorineural hearing loss types.

The Role of the GFI1 Protein in the Development of New Hearing Hair Cells

Researchers from the University of Maryland School of Medicine (UMSOM) identified the role of a protein in the development of new hearing hair cells. The result shows that in the absence of this protein, called GFI1, embryonic hair cells cannot develop into fully functional adult cells. The genes expressed by these cells are likely to develop into neuron-like cells. They believe that once the complex pathway to normal hearing is found, there is an opportunity to reverse hearing loss.

Other Hearing Loss Treatments

Until a cure for hearing loss is found, it is best to be mindful of maintaining your hearing health and prevent further irreparable hearing loss by seeking help from a hearing care professional. In a hearing consultation, the hearing care professional will evaluate your hearing health and recommend suitable treatment, and they might recommend a hearing aid.

Learn more about different hearing aid types by reading about the Top 6 Most Common Hearing Aid Styles.

Is There A Cure For Deafness?

If sensorineural hearing loss has developed to the point of profound hearing loss or deafness, it means the damage to the cells in the ear has become extremely severe. 

There is no cure for deafness, although some individuals may benefit from cochlear implants

As researchers are still working on trying to cure milder forms of hearing loss, it is, unfortunately, going to be a while until a deafness cure comes onto the horizon.


As of 2022, there is no cure for sensorineural hearing loss.

There are several projects underway to develop cures for sensorineural hearing loss. Despite disappointing results released in 2021, Frequency Therapeutics’ FX-322 remains the most promising candidate. If things go well, FX-322 could become available to the public within this decade.

In the meantime, take care of your hearing health and seek treatment if you have hearing loss.

Back to blog
1 of 3